Austrian Epigenome Editing Startup Epitome Therapeutics Raises €4 Million in Pre-Seed Round

Epitome Therapeutics, an Austrian BioTech startup focused on precision epigenome editing, secured €4 million in pre-seed funding led by XISTA Science Ventures and Caesar Ventures. The funding includes €2 million in equity and €2 million in non-dilutive grants. The company aims to develop its CADENCE platform for programmable gene expression and advance its first drug candidate.

Austrian Startup Launches GDPR-Compliant AI Agent as European Alternative to US Solutions

eustella, an Austrian startup, launched a GDPR-compliant AI agent aligned with European data protection laws. The AI uses models hosted in the EU, including Qwen 3.5, Gemma 4, and Mistral, and offers free and paid subscription tiers for features like web searches, travel planning, image generation, and collaborative projects.